New York, NY (PRWEB) May 18, 2014
Women who received a widely-used IUD for contraception continue to blame Bayer for their injuries in a consolidated litigation of Mirena lawsuits (http://www.themirenalawsuitcenter.com) that is steadily growing in New Jersey’s Bergen County Superior Court, Bernstein Liebhard LLP reports.
A Case List updated on May 15th indicates that 785 claims alleging spontaneous device migration, uterine perforations and other side effects have now been filed in the state proceeding on behalf of women who claim they were harmed by the IUD manufactured by Bayer Healthcare Pharmaceuticals. Plaintiffs allege they were inadequately warned about complications prior to IUD insertion by a health care provider, and accuse Bayer Healthcare Pharmaceuticals of downplaying risks that may be associated with its product. (In Re: Mirena Litigation; Case No. 297)
“We are not surprised to see more Mirena lawsuits being filed in the New Jersey litigation, as we continue to hear from women who allegedly experienced complications associated with device migration,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices like the Mirena IUD. The Firm is currently offering free and confidential case evaluations to women who may have been injured after spontaneous migration of the birth control implant.
Mirena IUD Lawsuits
As the number of Mirena IUD lawsuits in Bergen County continues to grow, court records indicate that hundreds more have been filed at the federal level. Court records updated on May 15th by the U.S. Judicial Panel on Multidistrict Litigation (JPML) indicate that 528 claims of IUD migration and other related complications are now pending in a multidistrict litigation underway in New York. Plaintiffs whose cases have been filed in the proceeding, which has been established in the U.S. District Court, Southern District of New York, allege similar side effects of the IUD. (In re: Mirena IUD Products Liability Litigation, MDL No. 2434)
Mirena was approved by the U.S. Food and Drug Administration (FDA) in 2000 as a contraceptive, and has expanded its range of uses since then. In 2009, the device became available as a treatment for heavy menstrual bleeding in women who used the implant for birth control. A 7 Action News report from August 2013 indicates that 70,000 adverse event reports of device dislocation, uterine perforations and other complications have been filed in the FDA’s adverse event report database since its entrance into the market.*
Among other things, lawsuits against Bayer similarly point to an FDA Warning Letter sent to the company in December 2009 that took issue with certain Mirena promotions that overstated the safety and efficacy of the device.
Women who allegedly experienced spontaneous migration of the IUD and other serious Mirena complications may be eligible to seek compensation for lost wages, out-of-pocket medical expenses and other damages. Learn more about Mirena complications by visiting Bernstein Liebhard LLP’s website and Facebook page: https://www.facebook.com/mirenalawsuithelp.
*wxyz.com/dpp/news/local_news/investigations/thousands-of-women-complain-about-dangerous-complications-from-mirena-iud-birth-control, 7 Action News, August 27, 2013
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients.
The Firm has been named by The National Law Journal to the Plaintiffs’ Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP represents the victims of defective drugs and medical devices on a contingency-fee basis, and our clients are never expected to pay attorneys fees unless their case results in a successful recovery on their behalf. New York State’s contingency fee cap rules generally limit those fees to 33 1/3% of the total recovery. As a result, the Firm’s fees can be significantly lower than those assessed by attorneys in other states, which depending on the law may amount to as much as 40% or more of a plaintiff’s recovery.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP
info (at) consumerinjurylawyers (dot) com